Oct 13, 2022 03:55PM emmaleah wrote:
Hi maggie, thanks, and all the best on all the issues you are managing and balancing. I agree that there is not much definitive research, and that we each need to make decisions about endocrine therapy as best we can in our individual situations and often without the benefit of much in the way of a prediction as to how we will do on it. I am glad to hear that your MO is supportive and that the absolute added risks are small, especially if counterbalanced against other important risks.
That 2021 paper on thyroid and estrogen has taken me aback by identifying exogenous thyroid hormone as a risk factor and an independent driver of ER+ breast cancer, almost as if it (thyroid hormone) were estrogen itself, which of course we are precisely trying to limit the effects of, when we do endocrine therapy.
Personally I need to take thyroid hormone (post-thyroidectomy for thyroid cancer), but I do want to monitor and keep the thyroid dose and TSH normal rather than high dose with low TSH (even though often recommended post thyca). I have sent my MO the paper and will ask next month when I see her about the various endocrine therapy options. I also submitted a question to the UCSF Bay Area Breast Cancer Forum to see if they (breast oncology team with a periodic public-facing online panel discussion) might have thoughts.
A lot of middle aged and older women are in both camps -- we take thyroid hormone and have had ER+ breast cancer. Hopefully some better guidance about endocrine therapy in the context of taking thyroid hormone can emerge from some of this.